Description

7-((Benzo[D]Thiazol-2-Ylamino)(4-(Difluoromethoxy)Phenyl)Methyl)Quinolin-8-Ol is a sophisticated organic compound featuring a quinoline core linked to a benzothiazole moiety via an aminomethyl bridge, with a difluoromethoxy phenyl substituent. This complex molecular architecture makes it a valuable advanced intermediate or building block for research and development in medicinal chemistry and material science. It is primarily sought by pharmaceutical R&D teams and specialty chemical manufacturers engaged in developing novel active ingredients or functional materials.

Application

• Pharmaceutical Intermediate: Serves as a key synthetic precursor for the development of novel drug candidates, particularly in therapeutic areas targeting specific enzymes or receptors.
• Medicinal Chemistry Research: Used as a core scaffold or building block in structure-activity relationship (SAR) studies and high-throughput screening libraries.
• Organic Light-Emitting Diode (OLED) Materials: Potential application as an electron-transporting or host material in OLED devices due to the conjugated quinoline and benzothiazole system.
• Fluorescent Probe Development: Can be utilized in the design of fluorescent sensors or bio-imaging agents, leveraging its inherent fluorophore properties.
• Agrochemical Research: Investigated as an intermediate for creating new active ingredients with potential herbicidal or fungicidal activity.
• Academic & Institutional Research: Employed in universities and research institutes for fundamental studies in organic synthesis and heterocyclic chemistry.

Basic Information

Item	Details
Product Name	7-((Benzo[D]Thiazol-2-Ylamino)(4-(Difluoromethoxy)Phenyl)Methyl)Quinolin-8-Ol
CAS No.	446826-86-4
Molecular Formula	C24H17F2N3O2S
Molecular Weight	449.47 g/mol
Synonyms	7-[(Benzo[d]thiazol-2-ylamino)(4-(difluoromethoxy)phenyl)methyl]quinolin-8-ol; 8-Quinolinol, 7-[(benzo[d]thiazol-2-ylamino)[4-(difluoromethoxy)phenyl]methyl]-; 7-((2-Benzothiazolylamino)(4-(difluoromethoxy)phenyl)methyl)-8-hydroxyquinoline; 446826-86-4; BTAQ Derivative; DFMP-Quinolinol-Benzothiazole
EINECS	Contact for details

Quality Control

Every batch of 7-((Benzo[D]Thiazol-2-Ylamino)(4-(Difluoromethoxy)Phenyl)Methyl)Quinolin-8-Ol is produced and tested under a strict quality management system. We provide comprehensive analytical data to ensure the identity, purity, and consistency required for critical R&D and scale-up processes. Certificates of Analysis (COA) detailing purity, impurities, and full characterization (NMR, HPLC-MS) are available for all shipments. Our quality commitment aligns with cGMP principles for advanced pharmaceutical intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). This compound is likely light-sensitive and should be handled under an inert atmosphere for long-term storage to prevent potential oxidation. Keep away from strong acids, bases, and oxidizing agents.

Specification

Item	Specification
Appearance	Yellow to light brown crystalline powder
Identification (HPLC-MS)	Conforms to structure
Identification (IR)	Conforms to reference
Purity (HPLC)	≥ 97.0% (Area %)
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.